Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways.
about
Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primatesThe vitamin D-antimicrobial peptide pathway and its role in protection against infectionRegulation of immune cell function by short-chain fatty acidsRegulation of the Intestinal Barrier Function by Host Defense PeptidesRole of the normal gut microbiotaHost-microbe interactions shaping the gastrointestinal environmentThe bacteriome-mycobiome interaction and antifungal host defenseDo antimicrobial peptides and complement collaborate in the intestinal mucosa?Fecal biomarkers of intestinal health and disease in childrenAntimicrobial proteins in intestine and inflammatory bowel diseasesPhenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategyLactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasisDiet, microorganisms and their metabolites, and colon cancer.Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen.Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.The role of the antimicrobial peptide cathelicidin in renal diseases.NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharideButyrate production in phylogenetically diverse Firmicutes isolated from the chicken caecum.Differential cathelicidin expression in duodenal and gastric biopsies from Tanzanian and German patients.Butyrate enhances disease resistance of chickens by inducing antimicrobial host defense peptide gene expression.Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.Immune and genetic gardening of the intestinal microbiome.Amniotic fluid cathelicidin in PPROM pregnancies: from proteomic discovery to assessing its potential in inflammatory complications diagnosis.Heterogeneity across the murine small and large intestine.Modulation of antimicrobial host defense peptide gene expression by free fatty acids.Inducing endogenous antimicrobial peptides to battle infections.Probiotics in the intensive care unit.The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiotaImproved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.Boosting innate immunity: development and validation of a cell-based screening assay to identify LL-37 inducers.Intestinal colonization: how key microbial players become established in this dynamic process: microbial metabolic activities and the interplay between the host and microbes.Induction of porcine host defense peptide gene expression by short-chain fatty acids and their analogs.Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitisContribution of microbiota to the intestinal physicochemical barrier.Expression and regulation of antimicrobial peptides in the gastrointestinal tract.Cathelicidins and innate defense against invasive bacterial infection.Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent.Assays for Identifying Inducers of the Antimicrobial Peptide LL-37.
P2860
Q21283760-00E1000F-AD16-4F65-AF24-52E9A7F8FA0AQ24647840-51B46CDD-8FC8-4AA2-8AC7-0DCD0B5CFC55Q26748416-8F8EB13A-8F1E-4C49-A221-2BD6759EE34DQ26776055-6599BBDB-9104-4A40-9E3C-1A1DF761FA68Q26798294-5F04DCEA-9298-4913-AE65-48DE0FCED2F3Q26829479-A71D1BE8-68B8-4FE3-B25A-D6900D27B5ECQ26851477-4B17ADA1-1C62-4B13-ABFF-1E4A3B7A90A9Q26865903-018C54D3-F67E-47A1-9722-53E14846A86CQ27021773-46794BC2-53D4-4DC2-AAB4-675BFD50BC46Q27023239-5B72D6BA-3BF2-4DEB-8996-F3D0EE24EDA3Q28478430-8999939B-4DBF-4169-8A3E-B11CD4C0815AQ28484943-3455172A-F109-4A4A-A213-9485AF60BE3DQ30241208-E5E8C2E0-56A2-4C32-9A56-826BCA128DF7Q31083153-EAA4AE52-7588-4B95-81E9-A1BBBA95FAF6Q33336048-4E7DFBE2-0118-49C9-85FE-02C8266C6A6EQ33403877-509B54E3-EC57-4463-BB79-5782B1A8ABA3Q33417340-1A86CD9E-5059-428F-828F-1EFD29615812Q33621811-76E43F42-3D72-4528-94A9-54A2E5373AB8Q33837381-A1094B87-5994-4AEE-81B4-D76009604A10Q33979642-E9B84FD5-4945-4F33-9CA8-8657A8853038Q34071870-F94517E0-2EF5-49A4-8FD2-5FCED365407AQ34091593-0664B17E-B3D2-4C84-BE9D-FAC6D0D0AFFBQ34143465-3E671E2C-7E1A-463C-AF1B-63BCE6B43254Q34345770-BB8F74C1-5A42-41F6-A4FB-D8B8FF0D56AAQ34467203-B458B674-4CF2-4100-B2C4-4148BE8CAD6DQ34482520-0E2DF3E2-0C27-4C4B-806E-2803ABA31580Q34534908-E1144BEF-5B68-4F3F-8BEB-731CAAC83C89Q34637205-9108025A-3B56-4AF7-A985-7CC0D4F0F321Q34647328-97B253AB-7164-4BDB-BC9C-2E2E5A1F793EQ34694936-E9FE8701-21E6-4893-B385-86691A9BD90AQ34864069-420C9E78-BBC1-4093-94B1-AE21AD3277AAQ34941943-41467A57-6E7E-4743-9129-4167D4861786Q34983653-243F9156-29C1-4547-A5BC-97C58EB66A41Q35032869-E011F75C-8C6E-4B26-80B5-3C43967AF402Q35292478-30739D47-CF7B-45EB-9A67-D017FF9A069BQ35550003-CBDD7026-308D-4B5E-85B6-F250D1F8629AQ35585098-D95FA4E6-B7F7-4F36-8CA4-1A2D2B1465F9Q35783492-CBBCE779-EA87-461B-BE0B-AD6CD6AA12D3Q35880704-3AF2D923-BDA2-4577-A873-111CC4055C4CQ36232935-527D64A6-C745-4D54-89D6-EECF6E7AE171
P2860
Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Expression of the cathelicidin ...... evance of signalling pathways.
@ast
Expression of the cathelicidin ...... evance of signalling pathways.
@en
Expression of the cathelicidin ...... evance of signalling pathways.
@nl
type
label
Expression of the cathelicidin ...... evance of signalling pathways.
@ast
Expression of the cathelicidin ...... evance of signalling pathways.
@en
Expression of the cathelicidin ...... evance of signalling pathways.
@nl
prefLabel
Expression of the cathelicidin ...... evance of signalling pathways.
@ast
Expression of the cathelicidin ...... evance of signalling pathways.
@en
Expression of the cathelicidin ...... evance of signalling pathways.
@nl
P2093
P2860
P356
P1433
P1476
Expression of the cathelicidin ...... evance of signalling pathways.
@en
P2093
B Agerberth
C Svanholm
G H Gudmundsson
J Schauber
W Scheppach
P2860
P304
P356
10.1136/GUT.52.5.735
P407
P577
2003-05-01T00:00:00Z